Can a broccoli compound help leukemia patients recover faster after transplant?
NCT ID NCT07297576
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether sulforaphane, a compound found in broccoli sprouts, can help blood cells recover faster after a cord blood transplant in adults with leukemia or related blood cancers. The trial will involve 36 patients and focus on safety and how quickly neutrophils (a type of white blood cell) return. If successful, it could make long-frozen cord blood a more reliable option for transplant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sulforaphane (a dietary supplement found in broccoli sprouts)
- What this could lead to
- If it works, this could help patients recover blood cells faster after a cord blood transplant, making long-frozen cord blood more usable.
- What could go wrong
- This is a very early, small study with only 36 people. It may not show clear benefits, and sulforaphane could cause side effects or not improve recovery at all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALL (ACUTE B-LYMPHOBLASTIC LEUKEMIA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute of Hematology, Blood Diseases Hospital
RECRUITINGTianjing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill boost the power of an existing leukemia treatment?
- Can umbilical cord blood keep leukemia at bay in older patients?
- Can a new drug combo reset the immune system to beat relapsed leukemia?
- Personalized dosing may improve stem cell transplant survival in blood cancer patients
- Could bone marrow from deceased donors cure blood cancers?
- Engineered immune cells take aim at Tough-to-Treat blood cancers